ReviewDrug safety2023

Long-Term Real-World Post-approval Safety Data of Multiple Biosimilars from One Marketing-Authorization Holder After More than 18 Years Since Their First Biosimilar Launch.

Sreedhar Sagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.